Form D · Other Health Care

North Texas Renal Management V, LLC

Dallas, TX · CIK 0001721564

Offering snapshot reported Apr 14, 2026 · SEC filing

Reported sold
$103K
Offering amount: $2.56M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 14, 2026Initial$102,500No comparison1SEC filing
Jan 7, 2025Initial$116,300No comparison1SEC filing
Jan 18, 2024Initial$388,800No comparison4SEC filing
Nov 6, 2017Initial$738,500No comparison63SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-580421

Source: Form D, filed Apr 14, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven M. Gieser Director, Executive
Steven M. Gieser, M.D. Director, Executive
Ali N/A Khalil Director
Ali Khalil, M.D. Director
Jyothsna M. Kodali Director, Executive
Jyothsna M. Kodali, M.D. Director
Jyosthsna Kodali, M.D. Director
Alexander Liang, M.D. Director, Executive
Daniel M. Richey Director
Daniel M. Richey, D.O. Director
Joris M Schuller, Jr., M.D. Director
Anupkumar Shetty, M.D. Director, Executive
Geoffrey S. Walker Director, Executive
Geoffrey Walker, M.D. Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1505 Lbj Freeway Suite 700
Dallas, TX, 75234